Xeljanz (tofacitinib)

pCPA File Number: 21103
Negotiation Status:
Active Negotiation
Indication(s):
Ulcerative Colitis
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
SR0572-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable